Inventor
QUEZADA SERGIO
GB15 patents
⚠️ This page may combine multiple inventors who share the name “QUEZADA SERGIO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TUSK THERAPEUTICS LTD
12 patentsUS10752691B2Aug 25, 2020
Anti-CD25 antibody agents
TUSK THERAPEUTICS LTD12 citations93
US10745485B2Aug 18, 2020
Anti-CD25 antibody agents
TUSK THERAPEUTICS LTD11 citations93
US10738125B2Aug 11, 2020
Anti-CD25 antibody agents
TUSK THERAPEUTICS LTD11 citations93
US11787866B2Oct 17, 2023
Anti-CD25 antibody agents
TUSK THERAPEUTICS LTD1 citations72
US11697688B2Jul 11, 2023
Anti-CD25 for tumour specific cell depletion
TUSK THERAPEUTICS LTD1 citations72
US11814434B2Nov 14, 2023
Anti-CD25 for tumour specific cell depletion
TUSK THERAPEUTICS LTD0 citations62
US11802160B2Oct 31, 2023
Anti-CD25 antibody agents
TUSK THERAPEUTICS LTD0 citations62
US11802161B2Oct 31, 2023
Anti-CD25 for tumour specific cell depletion
TUSK THERAPEUTICS LTD0 citations62
US11919960B2Mar 5, 2024
Anti-CD25 antibody agents
TUSK THERAPEUTICS LTD0 citations61
US11873341B2Jan 16, 2024
Anti-CD25 for tumour specific cell depletion
TUSK THERAPEUTICS LTD0 citations61
US11851494B2Dec 26, 2023
Anti-CD25 for tumour specific cell depletion
TUSK THERAPEUTICS LTD0 citations61
US11879014B2Jan 23, 2024
Method of treating cancer or depleting regulatory T cells in a subject by administering a human IGG1 anti-CD25 antibody
TUSK THERAPEUTICS LTD0 citations56